RESIQUIMOD - AN OVERVIEW

Risdiplam is the one orally administered drug accredited for your treatment of SMA. It absolutely was FDA approved in 2020 to be used in individuals two months of age and more mature, and it features as an SMN2 gene splicing modifier resulting in better levels of SMN protein. Oral administration is a big advantage of this drug as it can have an imp